Modulation of the typical multidrug resistance phenotype by targeting the MED-1 region of human MDR1 promoter
Authors:
- G DivitaGDG Divita
- J BernaudJBJ Bernaud
- D RigalDRD Rigal
- Lg BaggettoLBLg Baggetto
- 1 July 2000
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 7 (14) , 1224-1233
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 39 references indexed in Scilit:
- Secondary structure of P-glycoprotein investigated by circular dichroism and amino acid sequence analysisBiochimica et Biophysica Acta (BBA) - Biomembranes, 1998
- Biochemical, Genetic, and Metabolic Adaptations of Tumor Cells That Express the Typical Multidrug-Resistance Phenotype. Reversion by New TherapiesJournal of Bioenergetics and Biomembranes, 1997
- A Conserved Downstream Element Defines a New Class of RNA Polymerase II PromotersJournal of Biological Chemistry, 1995
- Differential utilization of multiple transcription start points accompanies the overexpression of the P-glycoprotein-encoding gene in Chinese hamster lung cellsGene, 1995
- Identification of a functional initiator sequence in the human MDR1 promoterBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1993
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- Binding protein-dependent transport systemsJournal of Bioenergetics and Biomembranes, 1990
- The “initiator” as a transcription control elementCell, 1989
- The mdrl gene, responsible for multidrug-resistance, codes for P-glycoproteinBiochemical and Biophysical Research Communications, 1986
- Isolation and expression of a complementary DNA that confers multidrug resistanceNature, 1986